博雅生物
(300294)
| 流通市值：74.23亿 | | | 总市值：74.23亿 |
| 流通股本：5.04亿 | | | 总股本：5.04亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 643,555,888.03 | 321,128,375.86 | 2,059,088,027.17 | 1,473,924,123.26 |
| 营业总成本 | 614,673,835.61 | 296,220,781.81 | 1,738,837,657.08 | 1,228,094,382.4 |
| 其他经营收益 | | | | |
| 营业利润 | 5,460,441.13 | 37,147,624.59 | 109,422,428.38 | 342,345,308.49 |
| 利润总额 | 3,426,035.43 | 36,003,508.55 | 103,878,495.08 | 341,334,751.51 |
| 净利润 | 50,884,883.53 | 30,033,392.25 | 112,638,772.02 | 343,042,957.61 |
| 每股收益 | | | | |
| 其他综合收益 | -10,184,885.93 | -5,943,787.21 | -5,885,761.41 | -3,039,859.77 |
| 综合收益总额 | 40,699,997.6 | 24,089,605.04 | 106,753,010.61 | 340,003,097.84 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,012,033,338 | 4,954,223,849.13 | 5,233,637,231.14 | 5,114,533,961.35 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,271,822,146.5 | 3,451,863,453.36 | 3,392,542,141.39 | 3,612,576,945.82 |
| 资产总计 | 8,283,855,484.5 | 8,406,087,302.49 | 8,626,179,372.53 | 8,727,110,907.17 |
| 流动负债: | | | | |
| 流动负债合计 | 698,989,703.01 | 784,509,138.11 | 1,033,795,419.63 | 918,495,852.52 |
| 非流动负债: | | | | |
| 非流动负债合计 | 141,777,265.21 | 158,289,882.79 | 153,185,276.35 | 136,166,290.87 |
| 负债合计 | 840,766,968.22 | 942,799,020.9 | 1,186,980,695.98 | 1,054,662,143.39 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 7,441,840,077.06 | 7,461,923,537.63 | 7,437,646,428.78 | 7,670,755,764.46 |
| 股东权益合计 | 7,443,088,516.28 | 7,463,288,281.59 | 7,439,198,676.55 | 7,672,448,763.78 |
| 负债和股东权益合计 | 8,283,855,484.5 | 8,406,087,302.49 | 8,626,179,372.53 | 8,727,110,907.17 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 706,619,011.8 | 349,111,915.07 | 1,856,187,215.04 | 1,363,006,049.57 |
| 经营活动现金流出小计 | 842,927,285.29 | 476,341,282.31 | 1,795,024,527.46 | 1,336,895,407.69 |
| 经营活动产生的现金流量净额 | -136,308,273.49 | -127,229,367.24 | 61,162,687.58 | 26,110,641.88 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,825,227,499.43 | 2,286,067,267.44 | 5,227,394,023.25 | 4,859,083,102.04 |
| 投资活动现金流出小计 | 3,010,468,913.25 | 2,468,543,430.76 | 5,908,308,549.07 | 5,222,844,043.06 |
| 投资活动产生的现金流量净额 | -185,241,413.82 | -182,476,163.32 | -680,914,525.82 | -363,760,941.02 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 11,230,000 | 11,230,000 | 48,035,988.7 | 2,162,988.7 |
| 筹资活动现金流出小计 | 44,157,399.49 | 4,424,857.87 | 203,105,364.17 | 201,272,412.81 |
| 筹资活动产生的现金流量净额 | -32,927,399.49 | 6,805,142.13 | -155,069,375.47 | -199,109,424.11 |
| 汇率变动对现金及现金等价物的影响 | -208,716.89 | -104,238.48 | -133,997.22 | -57,739.96 |
| 现金及现金等价物净增加额 | -354,685,803.69 | -303,004,626.91 | -774,955,210.93 | -536,817,463.21 |
| 期末现金及现金等价物余额 | 168,930,375.35 | 220,611,552.13 | 523,616,179.04 | 761,753,926.76 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -354,685,803.69 | - | -774,955,210.93 | - |